Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical reinfarction according to infarct location and reperfusion modality in patients with ST elevation myocardial infarction. A DANAMI-2 long-term follow-up substudy.
Busk M, Kristensen SD, Rasmussen K, Kelbaek H, Thayssen P, Madsen JK, Abildgaard U, Krusell LR, Mortensen LS, Thuesen L, Andersen HR, Nielsen TT; DANAMI-2 Investigators. Busk M, et al. Cardiology. 2009;113(1):72-80. doi: 10.1159/000171069. Epub 2008 Nov 13. Cardiology. 2009. PMID: 19005253
Does diabetes mellitus abolish the beneficial effect of primary coronary angioplasty on long-term risk of reinfarction after acute ST-segment elevation myocardial infarction compared with fibrinolysis? (A DANAMI-2 substudy).
Madsen MM, Busk M, Søndergaard HM, Bøttcher M, Mortensen LS, Andersen HR, Nielsen TT; DANAMI-2 Investigators. Madsen MM, et al. Among authors: busk m. Am J Cardiol. 2005 Dec 1;96(11):1469-75. doi: 10.1016/j.amjcard.2005.07.053. Epub 2005 Oct 11. Am J Cardiol. 2005. PMID: 16310424 Clinical Trial.
The Danish multicentre randomized study of fibrinolytic therapy vs. primary angioplasty in acute myocardial infarction (the DANAMI-2 trial): outcome after 3 years follow-up.
Busk M, Maeng M, Rasmussen K, Kelbaek H, Thayssen P, Abildgaard U, Vigholt E, Mortensen LS, Thuesen L, Kristensen SD, Nielsen TT, Andersen HR; DANAMI-2 Investigators. Busk M, et al. Eur Heart J. 2008 May;29(10):1259-66. doi: 10.1093/eurheartj/ehm392. Epub 2007 Oct 23. Eur Heart J. 2008. PMID: 17956874 Clinical Trial.
Timing, causes, and predictors of death after three years' follow-up in the Danish Multicenter Randomized Study of Fibrinolysis versus Primary Angioplasty in Acute Myocardial Infarction (DANAMI-2) trial.
Busk M, Maeng M, Kristensen SD, Thuesen L, Krusell LR, Mortensen LS, Steinmetz ER, Nielsen TT, Andersen HR; DANAMI-2 Investigators. Busk M, et al. Am J Cardiol. 2009 Jul 15;104(2):210-5. doi: 10.1016/j.amjcard.2009.03.014. Epub 2009 May 18. Am J Cardiol. 2009. PMID: 19576349 Clinical Trial.
Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy.
Maeng M, Nielsen PH, Busk M, Mortensen LS, Kristensen SD, Nielsen TT, Andersen HR; DANAMI-2 Investigators. Maeng M, et al. Among authors: busk m. Am J Cardiol. 2010 Jun 1;105(11):1528-34. doi: 10.1016/j.amjcard.2010.01.005. Epub 2010 Apr 14. Am J Cardiol. 2010. PMID: 20494656 Clinical Trial.
130 results